The majority of the council believes Axon Enterprise remains an exceptional operator in law enforcement technology with an enduring moat in body cameras, evidence management, and public safety cloud systems. Its recurring software revenue and mission-critical integration provide strategic durability; however, the financial inconsistencies and valuation multiples are stretched far beyond conservative thresholds. With a TTM ROIC reported at 22.3% but historical figures below 5%, investors face disconnects that undermine reliability of the compounding thesis. Buffett and Munger emphasize that a business losing money at the operating level, yet reporting net profits from accounting adjustments and tax anomalies, should not command a 60x earnings multiple. The doubling of debt from $677M to $1.36B alongside negative free cash flow exposes deterioration in capital discipline. While the company’s innovation and AI vision are commendable, they currently lack measurable financial returns. The council’s rational view is that Axon remains a “wonderful business” marred by a dangerously optimistic valuation and unusual working-capital buildup that questions cash conversion quality. The prudent investor should wait for earnings normalization before re-engaging. The consensus concludes that Axon should be revisited once valuation aligns with sustainable mid-cycle earnings around $3.00 per share and verifiable ROIC above 15% across several years. Under Buffett-Munger logic, the intelligent choice now is patience—the business quality is intact, but price is not. Until margins recover and accounting irregularities clarify, the group recommends “Buy Lower.” At an entry price near $130, Axon would offer a reasonable long-term compounding runway without sacrificing margin of safety.